WebDisclosure WebDisclosure
Basculer en Français
10400 Companies
217250 Keywords
146884 Articles
115003 Press releases
Headlines Articles Press releases CROSSJECT Remove
  1. Home
  2. Companies
  3. CROSSJECT
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 05/30/2024 at 10:30, 1 year 11 months ago

    Crossject annonce la publication de données cliniques sur ZEPIZURE® dans Neurology and Therapy

    Crossject annonce la publication de données cliniques sur ZEPIZURE® dans Neurology and Therapy, démontrant une bioéquivalence à Dormicum® pour traiter les crises d'épilepsie de manière plus efficace et sécurisée
    Sécurité Crossject Neurology And Therapy ZEPIZURE Bioéquivalence
    Logo of CROSSJECT
  • PRESS RELEASE

    published on 05/30/2024 at 10:30, 1 year 11 months ago

    Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy

    Crossject announces publication of clinical data on ZEPIZURE in Neurology and Therapy, highlighting bioequivalence versus Dormicum, early onset, and low variability
    Clinical Data Crossject Neurology And Therapy ZEPIZURE Needle-free Auto-injector
    Logo of CROSSJECT
Previous page
1 ... 11 12
Accesswire
  • Published on 05/13/2026 at 15:30, 1 hour 48 minutes ago

    All Things Mobile Analytic, Inc. (OTCID:ATMH) Acquires Metis Technology S.p.A., Strengthening European Enterprise Capabilities

  • Published on 05/13/2026 at 15:05, 2 hours 13 minutes ago

    Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services

  • Published on 05/13/2026 at 15:00, 2 hours 18 minutes ago

    ACCESS Newswire to Present at the LD Micro Invitational XVI on May 19th, at 2:00 pm ET

  • Published on 05/13/2026 at 15:00, 2 hours 18 minutes ago

    Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program

  • Published on 05/13/2026 at 14:35, 2 hours 43 minutes ago

    INEO Announces Patented INEO Welcoming DUO in Full Production with First Installation Underway in Leading UK Retailer

View all ACCESSWIRE
EQS Group
  • Published on 05/13/2026 at 16:50, 27 minutes ago

    Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility

  • Published on 05/13/2026 at 16:05, 1 hour 12 minutes ago

    PR Emerges as the Primary Source for Journalists in High-Pressure Newsrooms

  • Published on 05/13/2026 at 16:05, 1 hour 12 minutes ago

    Coupa and Celonis Collaborate to Eliminate Value Leakage Across Autonomous Spend Management

  • Published on 05/13/2026 at 15:57, 1 hour 21 minutes ago

    MLP SE: Invitation to the Annual General Meeting of MLP SE published

  • Published on 05/13/2026 at 15:45, 1 hour 32 minutes ago

    Remission Fund Opens to Compensate Victims of the AirBit Club Fraud

View all EQS
Les Echos
  • Published on 05/13/2026 at 16:00, 1 hour 18 minutes ago

    MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES

  • Published on 05/13/2026 at 16:00, 1 hour 18 minutes ago

    INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL

  • Published on 05/13/2026 at 14:31, 2 hours 46 minutes ago

    Statement of transactions in own shares from May 4, 2026 to May 8, 2026

  • Published on 05/13/2026 at 14:31, 2 hours 46 minutes ago

    Déclaration des transactions sur actions propres réalisées du 04/05/2026 au 08/05/2026

  • Published on 05/13/2026 at 12:27, 4 hours 50 minutes ago

    Franchisee Litigation - The Paris Court of Appeal Rules in Favor of Carrefour

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy